Ophthalmologists should encourage smoking cessation

Article

There is a need to introduce smoking cessation support into routine ophthalmic practice, according to a report published in the February issue of Eye.

There is a need to introduce smoking cessation support into routine ophthalmic practice, according to a report published in the February issue of Eye.

Simon Kelly and colleagues from the Royal Bolton Hospital, the University of Manchester, Bury Primary Care Trust, UK and the University of Otago, New Zealand conducted a cross-sectional survey using a postal questionnaire of all UK NHS hospital-based consultant ophthalmologists. The questionnaire looked at whether ophthalmologists identify the smoking status of their patients, advise about the increased risk of eye disease amongst smokers and whether they deliver smoking cessation advice. The availability of departmental smoking cessation resources was also ascertained.

Of the 886 ophthalmologists contacted, 485 responded (55%) and of the respondents, 79% were male. Only 35% of respondents asked about smoking status every time or most times for new patients and 5% for follow-up patients. Around 40% claimed to always or usually advise patients to give up smoking and 61% claimed to always or usually mention eye disease as a reason to quit. Just 14% assessed motivation to give up and 22% provide advice and assistance. Female ophthalmologists were more likely to undertake most aspects of smoking assessment and intervention. Only 18% of respondents stated that their department provides information about smoking for patients and 6% said that support is available for patients wanting to give up.

The results of this questionnaire indicate that smoking cessation support is not encouraged enough and should be routine in hospital-based ophthalmic departments.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.